AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.77 Million EUR | 35.91% |
| 2022 | 2.04 Million EUR | 6.5% |
| 2021 | 1.91 Million EUR | 4.77% |
| 2020 | 1.82 Million EUR | 15.66% |
| 2019 | 1.58 Million EUR | 0.22% |
| 2018 | 1.57 Million EUR | 8.29% |
| 2017 | 1.45 Million EUR | -14.69% |
| 2016 | 1.7 Million EUR | 0.3% |
| 2015 | 1.7 Million EUR | -14.1% |
| 2014 | 1.98 Million EUR | 78.63% |
| 2013 | 1.1 Million EUR | -6.92% |
| 2012 | 1.19 Million EUR | -16.22% |
| 2011 | 1.42 Million EUR | 79.7% |
| 2010 | 791.7 Thousand EUR | 32.54% |
| 2009 | 597.32 Thousand EUR | -68.41% |
| 2008 | 1.89 Million EUR | 1.47% |
| 2007 | 1.86 Million EUR | 31.53% |
| 2006 | 1.41 Million EUR | 24.52% |
| 2005 | 1.13 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.24 Million EUR | 1.56% |
| 2024 Q1 | 2.71 Million EUR | -2.23% |
| 2023 Q1 | 1.97 Million EUR | -3.37% |
| 2023 Q4 | 2.77 Million EUR | -8.17% |
| 2023 Q2 | 3.12 Million EUR | 58.69% |
| 2023 FY | 2.77 Million EUR | 35.91% |
| 2023 Q3 | 3.01 Million EUR | -3.48% |
| 2022 Q4 | 2.04 Million EUR | 16.91% |
| 2022 Q2 | 1.9 Million EUR | 4.72% |
| 2022 Q3 | 1.74 Million EUR | -8.18% |
| 2022 Q1 | 1.81 Million EUR | -5.26% |
| 2022 FY | 2.04 Million EUR | 6.5% |
| 2021 Q3 | 1.71 Million EUR | -7.89% |
| 2021 Q4 | 1.91 Million EUR | 11.43% |
| 2021 FY | 1.91 Million EUR | 4.77% |
| 2021 Q1 | 1.92 Million EUR | 5.25% |
| 2021 Q2 | 1.86 Million EUR | -3.01% |
| 2020 Q3 | 1.57 Million EUR | 9.43% |
| 2020 FY | 1.82 Million EUR | 15.66% |
| 2020 Q1 | 1.56 Million EUR | -1.2% |
| 2020 Q2 | 1.43 Million EUR | -8.03% |
| 2020 Q4 | 1.82 Million EUR | 16.33% |
| 2019 Q2 | 1.7 Million EUR | 6.97% |
| 2019 FY | 1.58 Million EUR | 0.22% |
| 2019 Q3 | 1.53 Million EUR | -10.01% |
| 2019 Q1 | 1.59 Million EUR | 1.32% |
| 2019 Q4 | 1.58 Million EUR | 2.75% |
| 2018 Q1 | 1.06 Million EUR | -27.04% |
| 2018 FY | 1.57 Million EUR | 8.29% |
| 2018 Q4 | 1.57 Million EUR | 5.32% |
| 2018 Q3 | 1.49 Million EUR | -6.37% |
| 2018 Q2 | 1.59 Million EUR | 50.51% |
| 2017 FY | 1.45 Million EUR | -14.69% |
| 2017 Q4 | 1.45 Million EUR | 2.13% |
| 2017 Q3 | 1.42 Million EUR | -10.01% |
| 2017 Q2 | 1.58 Million EUR | -0.47% |
| 2017 Q1 | 1.59 Million EUR | -6.74% |
| 2016 Q1 | 1.77 Million EUR | 4.42% |
| 2016 FY | 1.7 Million EUR | 0.3% |
| 2016 Q4 | 1.7 Million EUR | -4.48% |
| 2016 Q3 | 1.78 Million EUR | -0.66% |
| 2016 Q2 | 1.79 Million EUR | 1.22% |
| 2015 Q1 | 3.01 Million EUR | 52.21% |
| 2015 FY | 1.7 Million EUR | -14.1% |
| 2015 Q3 | 1.81 Million EUR | -39.23% |
| 2015 Q4 | 1.7 Million EUR | -6.29% |
| 2015 Q2 | 2.98 Million EUR | -0.89% |
| 2014 Q3 | 1.04 Million EUR | -8.59% |
| 2014 Q4 | 1.98 Million EUR | 90.24% |
| 2014 FY | 1.98 Million EUR | 78.63% |
| 2014 Q1 | 1.15 Million EUR | 4.17% |
| 2014 Q2 | 1.13 Million EUR | -1.39% |
| 2013 Q1 | 1.17 Million EUR | -1.35% |
| 2013 Q4 | 1.1 Million EUR | 23.95% |
| 2013 FY | 1.1 Million EUR | -6.92% |
| 2013 Q3 | 895.08 Thousand EUR | -26.51% |
| 2013 Q2 | 1.21 Million EUR | 3.58% |
| 2012 Q2 | 1.29 Million EUR | -6.74% |
| 2012 Q3 | 1.39 Million EUR | 7.02% |
| 2012 Q4 | 1.19 Million EUR | -14.27% |
| 2012 FY | 1.19 Million EUR | -16.22% |
| 2012 Q1 | 1.39 Million EUR | -2.09% |
| 2011 Q2 | 1.4 Million EUR | 74.81% |
| 2011 Q3 | 119.43 Million EUR | 8371.78% |
| 2011 FY | 1.42 Million EUR | 79.7% |
| 2011 Q4 | 1.42 Million EUR | -98.81% |
| 2011 Q1 | 806.47 Thousand EUR | 1.86% |
| 2010 FY | 791.7 Thousand EUR | 32.54% |
| 2010 Q1 | 671.21 Thousand EUR | 12.37% |
| 2010 Q4 | 791.7 Thousand EUR | 35.11% |
| 2010 Q3 | 585.96 Thousand EUR | -7.0% |
| 2010 Q2 | 630.09 Thousand EUR | -6.13% |
| 2009 FY | 597.32 Thousand EUR | -68.41% |
| 2009 Q4 | 597.32 Thousand EUR | 0.0% |
| 2008 FY | 1.89 Million EUR | 1.47% |
| 2007 FY | 1.86 Million EUR | 31.53% |
| 2006 FY | 1.41 Million EUR | 24.52% |
| 2005 FY | 1.13 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|